---
title: Life Sciences Venture Capital Monitor - Europe 12/2022 published - FCF Fox Corporate Finance GmbH
description: FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 12/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences ... Read more
---

[Research ](https://www.fcf.de/en/resources/research)

# [Life Sciences Venture Capital Monitor - Europe 12/2022 published - FCF Fox Corporate Finance GmbH](https://www.fcf.de/en/resources/research/life-sciences-venture-capital-monitor-europe-12-2022-published)

 Written by [FCF Healthcare & Life Sciences](https://www.fcf.de/en/resources/research/author/fcf-healthcare-life-sciences) | Feb 1, 2023 7:00:00 AM

FCF Fox Corporate Finance GmbH is delighted to publish the new “**FCF Life Sciences Venture Capital Monitor – Europe 12/2022**”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences sector.

**As of the end of December 2022 we identify the following current VC trends in Europe:**

- In 2022, overall Life Sciences funding has reached EUR 9,848m
- Top 5 Deals exceed EUR 140m each, largest transaction amounted to EUR 500m in Doctolib (France)
- Bpifrance (France) dominates the Top 5 Investors (by deal volume), followed by Eurazeo (France) and General Atlantic (United States)
- Biotech received 45% of the total investment volume, (+1% compared to the previous month)
- Oncology still dominates as the top indication in Biotechnology

To access the full report, please click [here](https://www.fcf.de/resources/research/download-request-fcf-healthcare-life-sciences-research-series-europe?hsLang=en).

[View full post](https://www.fcf.de/en/resources/research/life-sciences-venture-capital-monitor-europe-12-2022-published)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "FCF Healthcare & Life Sciences"
  },
  "dateModified" : "2025-11-11T15:36:44.339Z",
  "datePublished" : "2023-02-01T07:00:00Z",
  "headline" : "Life Sciences Venture Capital Monitor – Europe 12/2022 published",
  "image" : {
    "@type" : "ImageObject",
    "height" : 3563,
    "url" : "https://145785926.fs1.hubspotusercontent-eu1.net/hubfs/145785926/Website/Ressourcen/Healthcare_EU-Monitor_Shutterstock_2360267017_reduziert.jpeg",
    "width" : 9504
  },
  "mainEntityOfPage" : "https://www.fcf.de/en/resources/research/life-sciences-venture-capital-monitor-europe-12-2022-published",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Research"
  }
}
```